Clinical characteristics and functional motor outcomes of enterovirus 71 neurological disease in children

JAMA Neurology

Volumn 73, Issue 3, 2016, Pages 300-307

  Teoh, Hooi Ling ^a,b   Mohammad, Shekeeb S ^c,d   Britton, Philip N ^c,d,e   Kandula, Tejaswi ^e   Lorentzos, Michelle S ^c   Booy, Robert ^d,e,f   Jones, Cheryl A ^c,d,e   Rawlinson, William ^g   Ramachandran, Vidiya ^g   Rodriguez, Michael L ^h   Ian Andrews, P ^a   Dale, Russell C ^c,d   Farrar, Michelle A ^a,b   Sampaio, Hugo ^a,c  

^a SYDNEY CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e University of Sydney   (Australia)

^f National Centre for Immunization Research and Surveillance Sydney   (Australia)

^g PRINCE OF WALES HOSPITAL   (Australia)

^h NSW Health Pathology Western   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; VIRUS RNA;

5' UNTRANSLATED REGION; ARTICLE; ATAXIA; AUSTRALIA; BRAIN STEM; CEREBELLUM; CEREBROSPINAL FLUID; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DENTATE NUCLEUS; ENCEPHALOMYELITIS; ENTEROVIRUS 71; FECES; FEMALE; FLACCID PARALYSIS; GRAY MATTER; HUMAN; LABORATORY TEST; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MOTOR DYSFUNCTION; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROLOGICAL COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECOGNITION; RESUSCITATION; SPINAL CORD; SUBTHALAMIC NUCLEUS; TENDON REFLEX; THROAT CULTURE; TREATMENT RESPONSE; VOMITING; AUTONOMIC NERVOUS SYSTEM DISEASES; CENTRAL NERVOUS SYSTEM VIRAL DISEASES; COMPLICATION; ENCEPHALITIS, VIRAL; ENTEROVIRUS A; ENTEROVIRUS INFECTIONS; FOLLOW UP; INFANT; ISOLATION AND PURIFICATION; NEW SOUTH WALES; PARALYSIS; PATHOGENICITY; PRESCHOOL CHILD;

AUTONOMIC NERVOUS SYSTEM DISEASES; CENTRAL NERVOUS SYSTEM VIRAL DISEASES; CHILD, PRESCHOOL; ENCEPHALITIS, VIRAL; ENCEPHALOMYELITIS; ENTEROVIRUS A, HUMAN; ENTEROVIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; NEW SOUTH WALES; PARALYSIS;

EID: 84961763296     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2015.4388     Document Type: Article

References (40)

1. Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010;9(11):1097-1105.
2. Wang SM, Liu CC, Tseng HW, et al. Clinical spectrum of EV71 infection in southern Taiwan, with an emphasis on neurological complications. Clin Infect Dis. 1999;29:184-190.
3. Lee KY, Lee YJ, Kim TH, Cheon DS, Nam SO. Clinico-radiological spectrum in enterovirus 71 infection involving the central nervous system in children. J Clin Neurosci. 2014;21(3):416-420.
4. Zhang Q, MacDonald NE, Smith JC, et al. Severe enterovirus type 71 nervous system infections in children in the Shanghai region of China: clinical manifestations and implications for prevention and care. Pediatr Infect Dis J. 2014;33(5):482-487.
5. Cardosa J, Farrar J, Yeng C. A Guide to Clinical Management and Public Health Response for Hand, Foot and Mouth Disease (HFMD). Geneva, Switzerland:World Health OrganizationWestern Pacific Region; 2011.
6. Wang SM, Liu CC. Enterovirus 71: epidemiology, pathogenesis and management. Expert Rev Anti Infect Ther. 2009;7(6):735-742.
7. Chang LY, Lin TY, Hsu KH, et al. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet. 1999;354(9191):1682-1686.
8. Ooi MH, Wong SC, Mohan A, et al. Identification and validation of clinical predictors for the risk of neurological involvement in children with hand, foot, and mouth disease in Sarawak. BMC Infect Dis. 2009;9:3.
9. Ooi MH, Wong SC, Podin Y, et al. Human enterovirus 71 disease in Sarawak, Malaysia: A prospective clinical, virological, and molecular epidemiological study. Clin Infect Dis. 2007;44(5): 646-656.
10. Nagata N, Iwasaki T, Ami Y, et al. Differential localization of neurons susceptible to enterovirus 71 and poliovirus type 1 in the central nervous system of cynomolgus monkeys after intravenous inoculation. J Gen Virol. 2004;85(pt 10):2981-2989.
11. Hashimoto I, Hagiwara A, Kodama H. Neurovirulence in cynomolgus monkeys of enterovirus 71 isolated from a patient with hand, foot and mouth disease. Arch Virol. 1978;56(3): 257-261.
12. Lum LC, Wong KT, Lam SK, et al. Fatal enterovirus 71 encephalomyelitis. J Pediatr. 1998; 133(6):795-798.
13. Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010;10(11):778-790.
14. Wong KT, Munisamy B, Ong KC, et al. The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways. J Neuropathol Exp Neurol. 2008;67(2):162-169.
15. Yu P, Gao Z, Zong Y, et al. Distribution of enterovirus 71 RNA in inflammatory cells infiltrating different tissues in fatal cases of hand, foot, and mouth disease. Arch Virol. 2015;160(1):81-90.
16. Prager P, Nolan M, Andrews IP, Williams GD. Neurogenic pulmonary edema in enterovirus 71 encephalitis is not uniformly fatal but causes severe morbidity in survivors. Pediatr Crit Care Med. 2003;4(3):377-381.
17. Nolan MA, Craig ME, Lahra MM, et al. Survival after pulmonary edema due to enterovirus 71 encephalitis. Neurology. 2003;60(10):1651-1656.
18. Craig ME, Robertson P, Howard NJ, Silink M, Rawlinson WD. Diagnosis of enterovirus infection by genus-specific PCR and enzyme-linked immunosorbent assays. J Clin Microbiol. 2003;41 (2):841-844.
19. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604-607.
20. Mueller S, Wimmer E, Cello J. Poliovirus and poliomyelitis: A tale of guts, brains, and an accidental event. Virus Res. 2005;111(2):175-193.
21. Yu P, Gao Z, Zong Y, et al. Histopathological features and distribution of EV71 antigens and SCARB2 in human fatal cases and a mouse model of enterovirus 71 infection. Virus Res. 2014;189(0): 121-132.
22. Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med. 2009;15(7):794-797.
23. Lin YW, Yu SL, Shao HY, et al. Human SCARB2 transgenicmice as an infectious animal model for enterovirus 71. PLoS One. 2013;8(2):e57591. doi:10.1371/journal.pone.0057591.
24. Ku Z, Ye X, Shi J, Wang X, Liu Q, Huang Z. Single neutralizing monoclonal antibodies targeting the VP1 GH loop of enterovirus 71 inhibit both virus attachment and internalization during viral entry. J Virol. 2015;89(23):12084-12095.
25. Armangue T, Moris G, Cantarín-Extremera V, et al; Spanish Prospective Multicentric Study of Autoimmunity in Herpes Simplex Encephalitis. Autoimmune post-herpes simplex encephalitis of adults and teenagers. Neurology. 2015;85(20): 1736-1743.
26. Mohammad SS, Sinclair K, Pillai S, et al. Herpes simplex encephalitis relapse with chorea is associated with autoantibodies to N-Methyl-D-Aspartate receptor or dopamine-2 receptor. Mov Disord. 2014;29(1):117-122.
27. Messacar K, Schreiner TL, Maloney JA, et al. A cluster of acute flaccid paralysis and cranial nerve dysfunction temporally associated with an outbreak of enterovirus D68 in children in Colorado, USA. Lancet. 2015;385(9978):1662-1671.
28. McKinlay MA, Collett MS, Hincks JR, et al. Progress in the development of poliovirus antiviral agents and their essential role in reducing risks that threaten eradication. J Infect Dis. 2014;210(suppl 1): S447-S453.
29. Wang SM, Lei HY, Huang MC, et al. Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-Associated brainstem encephalitis. J Clin Virol. 2006;37(1):47-52.
30. Wang SM, Lei HY, Liu CC. Cytokine immunopathogenesis of enterovirus 71 brain stem encephalitis. Clin Dev Immunol. 2012;2012:876241.
31. Zeng M, Zheng X, Wei R, et al. The cytokine and chemokine profiles in patients with hand, foot and mouth disease of different severities in Shanghai, China, 2010. PLoS Negl Trop Dis. 2013;7(12):e2599. doi:10.1371/journal.pntd.0002599.
32. Kincaid O, Lipton HL. Viralmyelitis: An update. Curr Neurol Neurosci Rep. 2006;6(6):469-474.
33. Krishnan C, Kaplin AI, Deshpande DM, Pardo CA, Kerr DA. TransverseMyelitis: pathogenesis, diagnosis and treatment. Front Biosci. 2004;9: 1483-1499.
34. Defresne P, Meyer L, Tardieu M, et al. Efficacy of high dose steroid therapy in children with severe acute transversemyelitis. J Neurol Neurosurg Psychiatry. 2001;71(2):272-274.
35. Pyrgos V, Younus F. High-dose steroids in the management of acute flaccid paralysis due toWest Nile virus infection. Scand J Infect Dis. 2004;36 (6-7):509-512.
36. Wolf VL, Lupo PJ, Lotze TE. Pediatric acute transversemyelitis overview and differential diagnosis. J Child Neurol. 2012;27(11):1426-1436.
37. Tian H, Yang QZ, Liang J, Dong SY, Liu ZJ, Wang LX. Clinical features and management outcomes of severe hand, foot and mouth disease. Med Princ Pract. 2012;21(4):355-359.
38. Ooi MH, Solomon T, Podin Y, et al. Evaluation of different clinical sample types in diagnosis of human enterovirus 71-Associated hand-foot-And-mouth disease. J Clin Microbiol. 2007;45(6):1858-1866.
39. Tsai JD, Tsai HJ, Lin TH, Chang YY, Yang SH, Kuo HT. Comparison of the detection rates of RT-PCR and virus culture using a combination of specimens from multiple sites for enterovirus-Associated encephalomyelitis during enterovirus 71 epidemic. Jpn J Infect Dis. 2014;67 (5):333-338.
40. Pérez-Vélez CM, Anderson MS, Robinson CC, et al. Outbreak of neurologic enterovirus type 71 disease: A diagnostic challenge. Clin Infect Dis. 2007;45(8):950-957.